MENU
+Compare
THTX
Stock ticker: NASDAQ
AS OF
Jun 13 closing price
Price
$2.48
Change
-$0.05 (-1.98%)
Capitalization
114.38M

THTX Theratechnologies Forecast, Technical & Fundamental Analysis

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients... Show more

THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for THTX with price predictions
Jun 13, 2025

THTX's Stochastic Oscillator sits in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

THTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on THTX as a result. In of 114 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

THTX moved below its 50-day moving average on June 13, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. THTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.954). P/E Ratio (0.000) is within average values for comparable stocks, (59.376). THTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.335). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (1.388) is also within normal values, averaging (257.043).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

THTX is expected to report earnings to fall 30.00% to -7 cents per share on October 11

Theratechnologies THTX Stock Earnings Reports
Q3'23
Est.
$-0.07
Q2'23
Missed
by $0.04
Q1'23
Missed
by $0.06
Q4'22
Missed
by $0.01
Q3'22
Est.
$-0.08
The last earnings report on July 12 showed earnings per share of -10 cents, missing the estimate of -5 cents. With 201.02K shares outstanding, the current market capitalization sits at 114.38M.
A.I. Advisor
published General Information

General Information

a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV)

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2015, rue Peel
Phone
+1 514 336-7800
Employees
58
Web
https://www.theratech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LONGX14.33-0.09
-0.62%
Longboard I
WFINX54.36-0.62
-1.13%
Allspring Index C
RYCRX32.08-0.38
-1.17%
Rydex Real Estate C
VALIX13.31-0.16
-1.19%
Value Line Capital Appreciation Investor
WMGCX16.68-0.34
-2.00%
Macquarie Mid Cap Growth C

THTX and Stocks

Correlation & Price change

A.I.dvisor tells us that THTX and GNPX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that THTX and GNPX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THTX
1D Price
Change %
THTX100%
-1.98%
GNPX - THTX
27%
Poorly correlated
-6.77%
HOWL - THTX
26%
Poorly correlated
-5.43%
THRD - THTX
25%
Poorly correlated
+0.37%
SCPH - THTX
25%
Poorly correlated
-1.25%
KOD - THTX
24%
Poorly correlated
+5.43%
More